<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Invesco Growth Allocation Fund Class R — News on 6ix</title>
    <link>https://6ix.com/company/invesco-growth-allocation-fund-class-r</link>
    <description>Latest news and press releases for Invesco Growth Allocation Fund Class R on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/invesco-growth-allocation-fund-class-r" rel="self" type="application/rss+xml" />
    <item>
      <title>Northwest Biotherapeutics Announces Establishment Of the Company&apos;s Own Dedicated Leukapheresis Clinic</title>
      <link>https://6ix.com/company/invesco-growth-allocation-fund-class-r/news/northwest-biotherapeutics-announces-establishment-of-the-companys-own-dedicated-leukapheresis-clinic-5</link>
      <guid isPermaLink="true">https://6ix.com/company/invesco-growth-allocation-fund-class-r/news/northwest-biotherapeutics-announces-establishment-of-the-companys-own-dedicated-leukapheresis-clinic-5</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>BETHESDA, Md., April 21, 2026 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the &quot;Company&quot; or &quot;NWBio&quot;), a biotechnology company developing</description>
    </item>
  </channel>
</rss>